A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19

TD-0903 for ALI Associated With COVID-19

NCT04402866 ·Status: COMPLETED ·Phase: PHASE2

The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection

NCT04312997 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled APN01 Developed as Treatment for COVID-19

NCT05065645 ·Status: COMPLETED ·Phase: PHASE1

The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2

NCT04313023 ·Status: COMPLETED ·Phase: PHASE2

ACT-20 in Patients With Severe COVID-19 Pneumonia

NCT04398303 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Inhaled Nitric Oxide for Preventing Progression in COVID-19

NCT04388683 ·Status: TERMINATED ·Phase: PHASE2

A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis

NCT05349760 ·Status: WITHDRAWN ·Phase: PHASE2

Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 in Healthy Volunteers

NCT04868292 ·Status: COMPLETED ·Phase: PHASE1

ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19

NCT04604184 ·Status: TERMINATED ·Phase: PHASE2

A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19)

NCT04888949 ·Status: COMPLETED ·Phase: PHASE2

INB03 for the Treatment of Pulmonary Complications From COVID-19

NCT04370236 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis

NCT04596319 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise

NCT04472494 ·Status: TERMINATED ·Phase: PHASE2

AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF

NCT07194382 ·Status: RECRUITING ·Phase: PHASE2

Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection

NCT05616221 ·Status: COMPLETED ·Phase: PHASE2

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19

NCT04305457 ·Status: TERMINATED ·Phase: PHASE2

First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19

NCT04350736 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)

NCT04389671 ·Status: COMPLETED ·Phase: PHASE2

Sargramostim Use in COVID-19 to Recover Patient Health

NCT04707664 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19

NCT04681079 ·Status: COMPLETED

Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS

NCT03202394 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

NCT03591926 ·Status: WITHDRAWN ·Phase: PHASE2

Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes

NCT04830020 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia

NCT04561180 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy of Breathox Device Inhalation Therapy in the Treatment of Acute Symptoms Associated With COVID-19 and in the Prevention of the Use of Health Resources

NCT05196581 ·Status: COMPLETED ·Phase: PHASE2